Literature DB >> 6176651

Assays for the Sm and RNP autoantigens: the requirement for RNA and influence of the tissue source.

P J White, P B Billings, S O Hoch.   

Abstract

The disease systemic lupus erythematosus is characterized by antibodies directed against two nuclear antigens, designated Sm and RNP. The two antigens from any one tissue can be distinguished on the basis of the polypeptides recognized by anti-Sm and anti-RNP specific sera. Multiple polypeptides were associated with RNP isolated from rabbit thymus. To determine if these polypeptides were species-specific, a comparison was made of this antigen among different mammalian species. We report that the native RNP antigen has a m.w. of 70,000 and is readily susceptible to proteolysis generating smaller polypeptides that still retain antigenicity. Such an analysis also demonstrated multiple Sm-specific polypeptides, including species of 13,000 and 29,000 m.w. Because the immunoreactive species are protein in nature, the role of RNA for the detection of Sm and RNP by assay procedures such as immunodiffusion and counterimmunoelectrophoresis was examined. RNP, while still antigenically active, becomes insoluble after RNAse treatment; Sm remains largely soluble after such treatment. Both antigens can be reconstituted from their separated protein and RNA moieties with restoration of precipitin reactivity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176651

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Anti-Sm-RNP activity in sera of patients with rheumatic and autoimmune diseases.

Authors:  M Abu-Shakra; M Krup; H Slor; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1990-09       Impact factor: 2.980

2.  Structure of the sea urchin U1 RNA repeat.

Authors:  D T Brown; G F Morris; N Chodchoy; C Sprecher; W F Marzluff
Journal:  Nucleic Acids Res       Date:  1985-01-25       Impact factor: 16.971

3.  The detection of anti-Sm-RNP activity in sera of patients with monoclonal gammopathies.

Authors:  M Abu-Shakrah; M Krupp; S Argov; D Buskila; H Slor; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

4.  Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides.

Authors:  D G Williams; M R Stocks; P R Smith; R N Maini
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

5.  Molecular cloning of a cDNA encoding the human Sm-D autoantigen.

Authors:  L A Rokeach; J A Haselby; S O Hoch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

6.  Immunological characterization of small nuclear ribonucleoproteins reactive with sera of patients with systemic lupus erythematosus.

Authors:  M Ishaq; R Ali
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

7.  Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies.

Authors:  W H Reeves; D E Fisher; R G Lahita; H G Kunkel
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 8.  Purification of antigens and monoclonal antibodies.

Authors:  D Williams
Journal:  Clin Rheumatol       Date:  1987-06       Impact factor: 2.980

9.  Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization.

Authors:  J Ma; N King; S L Chen; R Penny; S N Breit
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

10.  Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B.

Authors:  J A Hardin; J O Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.